** U.S.-listed shares of Canada-based nutrition products firm Neptune Wellness Solutions down 9.8% premarket after bigger loss
** Q4 net loss was C$12.4 mln versus C$4.8 mln a year earlier
** Revenue in qtr fell to C$5.7 mln from C$7.0 mln in the year-ago quarter
** Co expect cannabis extraction revenue for Q1 2020 to be lower than $1 mln
** Brokerage GMP Securities says NEPT is positioned to be a leader in the North American cannabis industry, raises PT to $7.50 from C$6.52
** Average rating by 2 analysts covering stock is “buy”; their median PT is C$7.75
** Toronto-listed shares up ~88% YTD (Reporting By Arundhati Sarkar in Bengaluru)
Our Standards: The Thomson Reuters Trust Principles.